Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Effect of the Length of Second Stage of Labor in Primigravidae on Maternal & Neonatal Outcomes (RCT)

4 février 2016 mis à jour par: Mohamed El-Sharkawy, Kasr El Aini Hospital
The primary purpose of this study is to compare the effects of two different methods of care during the second stage of labor for nulliparous women (coached versus uncoached pushing) on the length of the second stage and how this may affect maternal and neonatal outcome.

Aperçu de l'étude

Description détaillée

The study was conducted on 434 primigravidae women admitted to Kasr El Ainy teaching Maternity Hospital for labor. The study will be done in the period between October 2015 and April 2016. The study will include 434 women with the diagnosis of the first stage of labor with at least cervical dilatation 4cm.

Ethical approval obtained and an informed consent will be taken from each patient after explaining the nature and scope of the study.

Methodology in details:

  1. Careful and detailed history taking regarding:

    • Personal history
    • Complaint.
    • History of present pregnancy.
    • Menstrual History.
    • Past history.
  2. Careful general examination.
  3. Abdominal examination.
  4. Local vaginal examination.
  5. Ultrasound examination.

Management of Cases:

Group (I)(Coached group):

It includes 217 patients who are admitted in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward. They are coached by the nurse to use closed-glottis and pushing three to four times during each contraction immediately when cervical dilation reached 10 cm and to continue pushing using this method with each contraction until birth. The nurse counts to 10 during each pushing effort to assist the woman in holding her breath for at least 10 seconds.

Group (II)(Uncoached group):

It includes 217 patients who are admitted early in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward at 10-cm cervical dilation where they remain until they feel the urge to push or the second stage had lasted 2 hours (whichever came first)., they are encouraged to bear down with contractions without holding their breath (open-glottis) for no more than 6-8 seconds and continue bearing down no more than three times with each contraction until birth. .

Patients admitted early in labor are subjected to active management of labor as follows:

Pelvic examination performed. Routine amniotomy performed and progress assessed. When dilatation is not increasing, a low dose protocol of oxytocin infusion will be started. Oxytocin diluted in the form of 5IU in 500 ml Ringer lactate making a concentration of nearly 1mu oxytocin/1ml Ringer solution. Infusion instituted at a rate of 1 -2 milliunit (15-30 drops) per minute and increased gradually in increments of 1 -2 milliunit per minute at 30 minutes interval, until at least three uterine contractions noted in a 10 minute period using cardio tocograph.

Assessment of each stage of labor was performed as follow:

  1. First stage of labor:

    It includes:

    • Duration of the first stage of labor.
    • Rate of cervical dilatation and foetal descent.
    • Adequacy of uterine contractions and documentation of labor dystocia.
    • Excess uterine activity consisted of uterine tachysystole, hypertonus or uterine hyperstimulation
  2. Second stage of labor:

    It includes:

    • Duration of the second stage.
    • Rate of the descent of foetus.
    • Monitoring of foetal heart rate every 5 minutes by sonicaid or continuous by CTG.
    • Use of mediolateral episiotomy.
    • Intervention will be considered either by instrumental delivery,fundal pressure or by CS If the second stage is prolonged more than 2 hours.
    • Monitoring of maternal oxygen saturation by pulse oximeter.
  3. Third stage of labor:

    - Duration of the third stage.

  4. Assessment of any vaginal laceration or perineal tears with their repair as well as repair of episiotomy.
  5. Assessment of quantity of blood loss and assessment of uterine atony(vital instability,number of soaked pads and hemoglobin drop) .
  6. Rate of caesarean section during varying stages of labor.
  7. Neonatal assessment:

It includes:

  • Foetal sex and body weight.
  • APGAR score at 1 and 5 minutes..

Type d'étude

Observationnel

Inscription (Anticipé)

434

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 35 ans (Adulte)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Femelle

Méthode d'échantillonnage

Échantillon de probabilité

Population étudiée

The study was conducted on 434 primigravidae women admitted to Kasr El Ainy teaching Maternity Hospital for labor. The study will be done in the period between October 2015 and April 2016. The study will include 434 women with the diagnosis of the first stage of labor with at least cervical dilatation 4cm.

La description

Inclusion Criteria:

All patients admitted in the first stage of labor with cervical dilatation of 4 cm at least:

  1. Women age 18-35 years.
  2. 37-41 weeks gestation pregnancy.
  3. Singleton pregnancy and vertex presentation.
  4. Women have no chronic or pregnancy-induced illnesses.
  5. Women are in established, spontaneous labor.

Exclusion Criteria:

  1. Malpresentation.
  2. Women with previous uterine scar.
  3. Multiple pregnancy
  4. Ante partum hemorrhage.
  5. Cephalopelvic disproportion.
  6. Women have chronic illnesses.
  7. Women with abnormal antenatal period.
  8. Patients with foetal distress
  9. Premature rupture of membrane
  10. Woman having any contraindication to vaginal delivery.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Modèles d'observation: Cas-témoins
  • Perspectives temporelles: Éventuel

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
1

Group (I)(Coached group):

It includes 217 patients who are admitted in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward. They are coached by the nurse to use closed-glottis and pushing three to four times during each contraction immediately when cervical dilation reached 10 cm and to continue pushing using this method with each contraction until birth. The nurse counts to 10 during each pushing effort to assist the woman in holding her breath for at least 10 seconds.

It includes 217 patients who are admitted in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward. They are coached by the nurse to use closed-glottis and pushing three to four times during each contraction immediately when cervical dilation reached 10 cm and to continue pushing using this method with each contraction until birth. The nurse counts to 10 during each pushing effort to assist the woman in holding her breath for at least 10 seconds.
2
It includes 217 patients who are admitted early in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward at 10-cm cervical dilation where they remain until they feel the urge to push or the second stage had lasted 2 hours (whichever came first)., they are encouraged to bear down with contractions without holding their breath (open-glottis) for no more than 6-8 seconds and continue bearing down no more than three times with each contraction until birth.
It includes 217 patients who are admitted early in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward at 10-cm cervical dilation where they remain until they feel the urge to push or the second stage had lasted 2 hours (whichever came first)., they are encouraged to bear down with contractions without holding their breath (open-glottis) for no more than 6-8 seconds and continue bearing down no more than three times with each contraction until birth. .

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Délai
Duration of the second stage
Délai: 0-3 hours
0-3 hours

Mesures de résultats secondaires

Mesure des résultats
Délai
Severe maternal morbidity e.g post partum hemorrhage
Délai: intrapartum and 2 hours postpartum.
intrapartum and 2 hours postpartum.
APGAR score after one and five minutes.
Délai: 1-5 minutes
1-5 minutes

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Directeur d'études: Kasr El Ainy, hospital, kasr el ainy street,cairo,egypt

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 novembre 2015

Achèvement primaire (Anticipé)

1 mai 2016

Achèvement de l'étude (Anticipé)

1 mai 2016

Dates d'inscription aux études

Première soumission

20 novembre 2015

Première soumission répondant aux critères de contrôle qualité

4 février 2016

Première publication (Estimation)

8 février 2016

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Estimation)

8 février 2016

Dernière mise à jour soumise répondant aux critères de contrôle qualité

4 février 2016

Dernière vérification

1 février 2016

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • KasrELAini maternity hospital

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner